Summary of Study ST001383

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000947. The data can be accessed directly via it's Project DOI: 10.21228/M88T2D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001383
Study TitleInvestigating exposures and health impacts of endocrine disrupting chemicals among inner-city children.
Study TypeObservational study
Study SummaryOur CHEAR project will conduct untargeted metabolomics analyses among children with and without asthma to gain insight into potential mechanisms related to asthma development. Metabolomics analysis will be conducted in a subset of participants from DISCOVER, a panel study enriched with low-income African American children in Baltimore, MD enrolled from 2009 to 2013. We will conduct untargeted metabolomics in serum collected from 15 children with non-atopic asthma and 22 non-atopic children without asthma. For each child, we will conduct analyses in two serum samples collected 3-9 months apart (total = 74 samples). We will use these pilot data to explore differences in metabolomic profiles among non-atopic children with asthma compared to non-asthmatic controls, and leverage repeated sample measures to assess differences in metabolomic profiles among asthmatic children by symptom frequency or severity. Finally, these data will be used to explore differences in metabolomic profiles by exposure status after urinary organophosphate flame retardant biomarkers have been quantified by CHEAR. Together, these analyses will provide pilot data for future work in our Center to assess potential mechanisms related to asthma development and severity as well as effects of organophoshate flame retardant exposures.
Institute
University of Michigan
DepartmentBiomedical Research Core Facilities
LaboratoryMetabolomics core
Last NameKachman
First NameMaureen
AddressAnn Arbor, MI
Emailmkachman@med.umich.edu
Phone734-232-0842
Submit Date2020-03-18
Raw Data AvailableYes
Raw Data File Type(s)d
Chear StudyYes
Analysis Type DetailLC-MS
Release Date2021-08-31
Release Version1
Maureen Kachman Maureen Kachman
https://dx.doi.org/10.21228/M88T2D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Project:

Project ID:PR000947
Project DOI:doi: 10.21228/M88T2D
Project Title:Health impacts of endocrine disrupting chemicals
Project Type:Observational study
Project Summary:Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children.
Institute:University of Michigan
Department:Nutritional Sciences
Laboratory:Meeker Lab
Last Name:Meeker
First Name:John
Address:Ann Arbor, MI
Email:meekerj@umich.edu
Phone:734-764-7184

Subject:

Subject ID:SU001457
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Gender
SA100979R00CHRPL1-3CHEAR | Condition:CHEAR
SA100980R00CHRPL1-2CHEAR | Condition:CHEAR
SA100981R00CHRPL1-4CHEAR | Condition:CHEAR
SA100982R00CHRPL1-1CHEAR | Condition:CHEAR
SA100983C-1NYP2-S-00Female | Condition:asthmatic
SA100984C-1NYQ0-S-00Female | Condition:asthmatic
SA100985C-1NYR8-S-00Female | Condition:asthmatic
SA100986C-1NYJ5-S-00Female | Condition:asthmatic
SA100987C-1NYK3-S-00Female | Condition:asthmatic
SA100988C-1NYU1-S-00Female | Condition:asthmatic
SA100989C-1NY93-S-00Female | Condition:asthmatic
SA100990C-1NY44-S-00Female | Condition:asthmatic
SA100991C-1NYX4-S-00Female | Condition:asthmatic
SA100992C-1NZ76-S-00Female | Condition:asthmatic
SA100993C-1NZ68-S-00Female | Condition:asthmatic
SA100994C-1NY51-S-00Female | Condition:asthmatic
SA100995C-1NYW7-S-00Female | Condition:asthmatic
SA100996C-1NYN6-S-00Female | Condition:asthmatic
SA100997C-1NY85-S-00Female | Condition:asthmatic
SA100998C-1NYV9-S-00Female | Condition:asthmatic
SA100999C-1P025-S-00Female | Condition:control
SA101000C-1P017-S-00Female | Condition:control
SA101001C-1NZD7-S-00Female | Condition:control
SA101002C-1NZN5-S-00Female | Condition:control
SA101003C-1NZM8-S-00Female | Condition:control
SA101004C-1NZP1-S-00Female | Condition:control
SA101005C-1NZS4-S-00Female | Condition:control
SA101006C-1NZT2-S-00Female | Condition:control
SA101007C-1NZL0-S-00Female | Condition:control
SA101008C-1NZK2-S-00Female | Condition:control
SA101009C-1NZ50-S-00Female | Condition:control
SA101010C-1NZG1-S-00Female | Condition:control
SA101011C-1NZH9-S-00Female | Condition:control
SA101012C-1NZJ4-S-00Female | Condition:control
SA101013C-1NZC0-S-00Female | Condition:control
SA101014C-1NYT3-S-00Female | Condition:control
SA101015C-1NYF4-S-00Female | Condition:control
SA101016C-1NZ43-S-00Female | Condition:control
SA101017C-1NYS5-S-00Female | Condition:control
SA101018C-1NYE6-S-00Female | Condition:control
SA101019C-1NY77-S-00Male | Condition:asthmatic
SA101020C-1NYA5-S-00Male | Condition:asthmatic
SA101021C-1NYB3-S-00Male | Condition:asthmatic
SA101022C-1NY69-S-00Male | Condition:asthmatic
SA101023C-1NY36-S-00Male | Condition:asthmatic
SA101024C-1NXY3-S-00Male | Condition:asthmatic
SA101025C-1NY28-S-00Male | Condition:asthmatic
SA101026C-1NYD8-S-00Male | Condition:asthmatic
SA101027C-1NYC1-S-00Male | Condition:asthmatic
SA101028C-1NXX5-S-00Male | Condition:asthmatic
SA101029C-1P009-S-00Male | Condition:asthmatic
SA101030C-1NZY1-S-00Male | Condition:asthmatic
SA101031C-1NZW6-S-00Male | Condition:control
SA101032C-1P033-S-00Male | Condition:control
SA101033C-1NZX3-S-00Male | Condition:control
SA101034C-1P058-S-00Male | Condition:control
SA101035C-1P041-S-00Male | Condition:control
SA101036C-1NZV8-S-00Male | Condition:control
SA101037C-1P066-S-00Male | Condition:control
SA101038C-1NZB2-S-00Male | Condition:control
SA101039C-1NYL1-S-00Male | Condition:control
SA101040C-1NYM9-S-00Male | Condition:control
SA101041C-1NZ27-S-00Male | Condition:control
SA101042C-1NZU0-S-00Male | Condition:control
SA101043C-1NYG2-S-00Male | Condition:control
SA101044C-1NY02-S-00Male | Condition:control
SA101045C-1NY10-S-00Male | Condition:control
SA101046C-1NZ35-S-00Male | Condition:control
SA101047C-1NYH0-S-00Male | Condition:control
SA101048C-1NZR7-S-00Male | Condition:control
SA101049C-1NZ84-S-00Male | Condition:control
SA101050C-1NZF3-S-00Male | Condition:control
SA101051C-1NZQ9-S-00Male | Condition:control
SA101052C-1NZ92-S-00Male | Condition:control
SA101053C-1NZE5-S-00Male | Condition:control
SA101054C-1NZA4-S-00Male | Condition:control
SA101055Master pool-08POOL | Condition:POOL
SA101056Master pool-09POOL | Condition:POOL
SA101057Master pool-10POOL | Condition:POOL
SA101058Master pool-07POOL | Condition:POOL
SA101059Master pool-03POOL | Condition:POOL
SA101060Master pool-01POOL | Condition:POOL
SA101061Master pool-02POOL | Condition:POOL
SA101062Master pool-04POOL | Condition:POOL
SA101063Master pool-05POOL | Condition:POOL
SA101064Master pool-06POOL | Condition:POOL
Showing results 1 to 86 of 86

Collection:

Collection ID:CO001452
Collection Summary:Standard blood serum collection protocol
Sample Type:Blood (serum)
Storage Conditions:-80℃

Treatment:

Treatment ID:TR001472
Treatment Summary:This is observational study

Sample Preparation:

Sampleprep ID:SP001465
Sampleprep Summary:Standard untargeted metabolomics sample preparation (see enclosed protocol)

Combined analysis:

Analysis ID AN002304 AN002305 AN002306 AN002307
Analysis type MS MS MS MS
Chromatography type Reversed phase Reversed phase Reversed phase Reversed phase
Chromatography system Agilent 1290 Infinity II Agilent 1290 Infinity II Agilent 1290 Infinity II Agilent 1290 Infinity II
Column Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um)
MS Type ESI ESI ESI ESI
MS instrument type QTOF QTOF QTOF QTOF
MS instrument name Agilent 6540 QTOF Agilent 6540 QTOF Agilent 6540 QTOF Agilent 6540 QTOF
Ion Mode POSITIVE NEGATIVE POSITIVE NEGATIVE
Units Peak area normalized Peak area normalized Peak area normalized Peak area normalized

Chromatography:

Chromatography ID:CH001693
Chromatography Summary:RP-LCMS-Positive
Instrument Name:Agilent 1290 Infinity II
Column Name:Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um)
Chromatography Type:Reversed phase
  
Chromatography ID:CH001694
Chromatography Summary:RP-LCMS-Negative
Instrument Name:Agilent 1290 Infinity II
Column Name:Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um)
Chromatography Type:Reversed phase

MS:

MS ID:MS002147
Analysis ID:AN002304
Instrument Name:Agilent 6540 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Untargeted recursive search (Agilent Qual/MPP/In-house software)
Ion Mode:POSITIVE
  
MS ID:MS002148
Analysis ID:AN002305
Instrument Name:Agilent 6540 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Untargeted recursive search (Agilent Qual/MPP/In-house software)
Ion Mode:NEGATIVE
  
MS ID:MS002149
Analysis ID:AN002306
Instrument Name:Agilent 6540 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Targeted search (Agilent ProFinder)
Ion Mode:POSITIVE
  
MS ID:MS002150
Analysis ID:AN002307
Instrument Name:Agilent 6540 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Targeted search (Agilent ProFinder)
Ion Mode:NEGATIVE
  logo